GT Biopharma, Inc. (GTBP) stock
GTBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.43+0.25 (+7.86%)
Close on Nov 18, 2026Market cap $154.73MP/E –Yield –
GT Biopharma market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
GT Biopharma's market cap was $100.86M on Nov 11, 2026, against $119.54M a year earlier. Over the last 5 years it ranged from $47.99M to $2.55B, with a median of $207.09M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $100.86M | -15.1% |
| 2025 | Dec 31, 2025 | $118.80M | -30.3% |
| 2024 | Dec 31, 2024 | $170.37M | -35.5% |
| 2023 | Dec 29, 2023 | $264.07M | -63.5% |
| 2022 | Dec 30, 2022 | $723.29M | +81.8% |
| 2021 | Dec 31, 2021 | $397.92M | -97.2% |
| 2020 | Dec 31, 2020 | $13.97B | +506.6% |
| 2019 | Dec 31, 2019 | $2.30B | -83.4% |
| 2018 | Dec 31, 2018 | $13.88B | -85.3% |
| 2017 | Dec 29, 2017 | $94.14B | – |
See a number that looks wrong?